AAPL345.69+3.69 (+1.08%) ▲|ABBV284.76+1.36 (+0.48%) ▲|ABT104.56-0.12 (-0.11%) ▼|ACN226.79+1.87 (+0.83%) ▲|ADBE245.41-6.26 (-2.49%) ▼|AMAT416.22-13.79 (-3.21%) ▼|AMD540.97-21.26 (-3.78%) ▼|AMGN435.21+1.18 (+0.27%) ▲|AMT184.49+3.13 (+1.73%) ▲|AMZN253.39-1.37 (-0.54%) ▼|AVGO333.96-10.37 (-3.01%) ▼|AXP316.28+2.41 (+0.77%) ▲|BA189.00+0.27 (+0.14%) ▲|BAC52.14+0.44 (+0.85%) ▲|BKNG165.75-0.06 (-0.03%) ▼|BLK1,135.44+14.66 (+1.31%) ▲|BMY60.60+0.03 (+0.05%) ▲|BNY143.30+1.21 (+0.85%) ▲|BRK-B529.60+3.92 (+0.74%) ▲|C125.41+2.20 (+1.78%) ▲|CAT737.56+1.92 (+0.26%) ▲|CL93.70+1.03 (+1.11%) ▲|CMCSA22.25+0.48 (+2.18%) ▲|COF201.81+2.95 (+1.48%) ▲|COP144.70+2.97 (+2.10%) ▲|COST990.58+12.57 (+1.29%) ▲|CRM239.28-7.46 (-3.02%) ▼|CSCO108.10-1.76 (-1.60%) ▼|CVS92.88+0.30 (+0.32%) ▲|CVX222.51+3.19 (+1.45%) ▲|DE641.25-9.42 (-1.45%) ▼|DHR230.18-1.33 (-0.57%) ▼|DIS111.59+0.91 (+0.82%) ▲|DUK120.86+1.98 (+1.67%) ▲|EMR161.70-0.45 (-0.28%) ▼|FDX292.73-2.82 (-0.95%) ▼|GD341.67+4.64 (+1.38%) ▲|GE317.07+5.07 (+1.63%) ▲|GEV928.95+2.51 (+0.27%) ▲|GILD156.37-1.00 (-0.64%) ▼|GM84.92+1.26 (+1.51%) ▲|GOOG339.95-4.96 (-1.44%) ▼|GOOGL343.72-5.50 (-1.57%) ▼|GS890.30-0.98 (-0.11%) ▼|HD312.36+4.12 (+1.34%) ▲|HON211.93+1.43 (+0.68%) ▲|IBM231.76-2.36 (-1.01%) ▼|INTC91.16-4.22 (-4.42%) ▼|INTU323.04-7.13 (-2.16%) ▼|ISRG429.27+1.41 (+0.33%) ▲|JNJ255.45+2.17 (+0.85%) ▲|JPM341.07+5.54 (+1.65%) ▲|KO93.38+1.38 (+1.50%) ▲|LIN498.82+5.60 (+1.14%) ▲|LLY1,262.18+10.57 (+0.84%) ▲|LMT544.12+11.48 (+2.16%) ▲|LOW198.24+2.52 (+1.29%) ▲|LRCX268.61-8.86 (-3.19%) ▼|MA617.04+0.72 (+0.12%) ▲|MCD243.43+0.93 (+0.38%) ▲|MDLZ64.12+1.09 (+1.73%) ▲|MDT94.70-0.75 (-0.79%) ▼|META720.00-16.72 (-2.27%) ▼|MMM164.77-0.57 (-0.34%) ▼|MO74.76+0.92 (+1.24%) ▲|MRK146.74+1.55 (+1.07%) ▲|MS182.61+0.51 (+0.28%) ▲|MSFT528.56-10.88 (-2.02%) ▼|MU895.72-35.52 (-3.81%) ▼|NEE79.92+0.96 (+1.22%) ▲|NFLX70.82-1.79 (-2.47%) ▼|NKE37.44+0.30 (+0.81%) ▲|NOW140.11-8.46 (-5.69%) ▼|NVDA217.01-0.22 (-0.10%) ▼|ORCL129.62-4.86 (-3.61%) ▼|PEP131.21+2.83 (+2.20%) ▲|PFE29.59+0.15 (+0.49%) ▲|PG159.22+2.14 (+1.36%) ▲|PLTR187.33-13.18 (-6.57%) ▼|PM204.24+4.34 (+2.17%) ▲|QCOM176.07-2.33 (-1.31%) ▼|RTX191.39+4.44 (+2.38%) ▲|SBUX97.08+0.20 (+0.20%) ▲|SCHW92.40-1.76 (-1.87%) ▼|SO90.69+1.51 (+1.69%) ▲|SPG204.92+1.53 (+0.75%) ▲|T23.64+0.14 (+0.57%) ▲|TMO686.16-10.33 (-1.48%) ▼|TMUS158.50+1.47 (+0.94%) ▲|TSLA358.11-4.33 (-1.20%) ▼|TXN281.87+2.75 (+0.99%) ▲|UBER70.67-0.61 (-0.85%) ▼|UNH400.94-5.74 (-1.41%) ▼|UNP287.74-0.98 (-0.34%) ▼|UPS97.28-0.55 (-0.56%) ▼|USB58.40+1.01 (+1.76%) ▲|V402.47+2.72 (+0.68%) ▲|VZ44.74+0.34 (+0.75%) ▲|WFC83.79+1.04 (+1.26%) ▲|WMT118.37+0.50 (+0.42%) ▲|XOM176.64+1.96 (+1.12%) ▲|AAPL345.69+3.69 (+1.08%) ▲|ABBV284.76+1.36 (+0.48%) ▲|ABT104.56-0.12 (-0.11%) ▼|ACN226.79+1.87 (+0.83%) ▲|ADBE245.41-6.26 (-2.49%) ▼|AMAT416.22-13.79 (-3.21%) ▼|AMD540.97-21.26 (-3.78%) ▼|AMGN435.21+1.18 (+0.27%) ▲|AMT184.49+3.13 (+1.73%) ▲|AMZN253.39-1.37 (-0.54%) ▼|AVGO333.96-10.37 (-3.01%) ▼|AXP316.28+2.41 (+0.77%) ▲|BA189.00+0.27 (+0.14%) ▲|BAC52.14+0.44 (+0.85%) ▲|BKNG165.75-0.06 (-0.03%) ▼|BLK1,135.44+14.66 (+1.31%) ▲|BMY60.60+0.03 (+0.05%) ▲|BNY143.30+1.21 (+0.85%) ▲|BRK-B529.60+3.92 (+0.74%) ▲|C125.41+2.20 (+1.78%) ▲|CAT737.56+1.92 (+0.26%) ▲|CL93.70+1.03 (+1.11%) ▲|CMCSA22.25+0.48 (+2.18%) ▲|COF201.81+2.95 (+1.48%) ▲|COP144.70+2.97 (+2.10%) ▲|COST990.58+12.57 (+1.29%) ▲|CRM239.28-7.46 (-3.02%) ▼|CSCO108.10-1.76 (-1.60%) ▼|CVS92.88+0.30 (+0.32%) ▲|CVX222.51+3.19 (+1.45%) ▲|DE641.25-9.42 (-1.45%) ▼|DHR230.18-1.33 (-0.57%) ▼|DIS111.59+0.91 (+0.82%) ▲|DUK120.86+1.98 (+1.67%) ▲|EMR161.70-0.45 (-0.28%) ▼|FDX292.73-2.82 (-0.95%) ▼|GD341.67+4.64 (+1.38%) ▲|GE317.07+5.07 (+1.63%) ▲|GEV928.95+2.51 (+0.27%) ▲|GILD156.37-1.00 (-0.64%) ▼|GM84.92+1.26 (+1.51%) ▲|GOOG339.95-4.96 (-1.44%) ▼|GOOGL343.72-5.50 (-1.57%) ▼|GS890.30-0.98 (-0.11%) ▼|HD312.36+4.12 (+1.34%) ▲|HON211.93+1.43 (+0.68%) ▲|IBM231.76-2.36 (-1.01%) ▼|INTC91.16-4.22 (-4.42%) ▼|INTU323.04-7.13 (-2.16%) ▼|ISRG429.27+1.41 (+0.33%) ▲|JNJ255.45+2.17 (+0.85%) ▲|JPM341.07+5.54 (+1.65%) ▲|KO93.38+1.38 (+1.50%) ▲|LIN498.82+5.60 (+1.14%) ▲|LLY1,262.18+10.57 (+0.84%) ▲|LMT544.12+11.48 (+2.16%) ▲|LOW198.24+2.52 (+1.29%) ▲|LRCX268.61-8.86 (-3.19%) ▼|MA617.04+0.72 (+0.12%) ▲|MCD243.43+0.93 (+0.38%) ▲|MDLZ64.12+1.09 (+1.73%) ▲|MDT94.70-0.75 (-0.79%) ▼|META720.00-16.72 (-2.27%) ▼|MMM164.77-0.57 (-0.34%) ▼|MO74.76+0.92 (+1.24%) ▲|MRK146.74+1.55 (+1.07%) ▲|MS182.61+0.51 (+0.28%) ▲|MSFT528.56-10.88 (-2.02%) ▼|MU895.72-35.52 (-3.81%) ▼|NEE79.92+0.96 (+1.22%) ▲|NFLX70.82-1.79 (-2.47%) ▼|NKE37.44+0.30 (+0.81%) ▲|NOW140.11-8.46 (-5.69%) ▼|NVDA217.01-0.22 (-0.10%) ▼|ORCL129.62-4.86 (-3.61%) ▼|PEP131.21+2.83 (+2.20%) ▲|PFE29.59+0.15 (+0.49%) ▲|PG159.22+2.14 (+1.36%) ▲|PLTR187.33-13.18 (-6.57%) ▼|PM204.24+4.34 (+2.17%) ▲|QCOM176.07-2.33 (-1.31%) ▼|RTX191.39+4.44 (+2.38%) ▲|SBUX97.08+0.20 (+0.20%) ▲|SCHW92.40-1.76 (-1.87%) ▼|SO90.69+1.51 (+1.69%) ▲|SPG204.92+1.53 (+0.75%) ▲|T23.64+0.14 (+0.57%) ▲|TMO686.16-10.33 (-1.48%) ▼|TMUS158.50+1.47 (+0.94%) ▲|TSLA358.11-4.33 (-1.20%) ▼|TXN281.87+2.75 (+0.99%) ▲|UBER70.67-0.61 (-0.85%) ▼|UNH400.94-5.74 (-1.41%) ▼|UNP287.74-0.98 (-0.34%) ▼|UPS97.28-0.55 (-0.56%) ▼|USB58.40+1.01 (+1.76%) ▲|V402.47+2.72 (+0.68%) ▲|VZ44.74+0.34 (+0.75%) ▲|WFC83.79+1.04 (+1.26%) ▲|WMT118.37+0.50 (+0.42%) ▲|XOM176.64+1.96 (+1.12%) ▲|
18.5 C
New York
Friday, October 16, 2026

Tag: therapy

Over $4 Million Raised to Brighten Patients’ Futures at Nicklaus Children’s Hospital’s 19th Annual Diamond Ball

This year's signature fundraising event was hosted by radio co-hosts, Enrique Santos and Dayanara Torres and featured powerful patient stories of resilience, innovation and...

Actinium Pharmaceuticals Appoints Radiopharmaceutical Industry Veteran Sean Maenpaa as Senior Vice President, Business Development

– Brings more than 20 years of oncology business development and commercial leadership, including senior roles across the radiopharmaceutical sector at Bayer, Clovis Oncology,...

Sobi receives positive CHMP opinion for TRYNGOLZA® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG)

Positive CHMP opinion based on Phase 3 CORE and CORE2 results, demonstrating a statistically significant placebo-adjusted mean reduction of up to 72% in triglyceride...

Perceptive Discovery Launches Astatine-211 Study Capabilities in the US and UK

Perceptive Discovery becomes the first US provider able to support At-211 studies, expanding access to specialized radiopharmaceutical development infrastructure through its collaboration with Atley...

10 TWC Scholars Listed among World’s Top 2% Scientists 2026

HONG KONG, Oct. 16, 2026 /PRNewswire/ -- Ten scholars from Tung Wah College (TWC) have been listed among the World's Top 2% Scientists in the...

Jyong Biotech Announces Proposed Texas Facility to Support Potential Commercialization of Its Drug Candidates

NEW TAIPEI CITY, Oct. 16, 2026 /PRNewswire/ -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to...

Cancer Diagnostics Market to Reach US$ 41.5 Billion by 2031 at 7.2% CAGR, says Wissen Research

Sheridan, WY, Oct. 15, 2026 /PRNewswire/ -- The global cancer diagnostics market is valued at USD 29.3 billion in 2026 and is projected to reach...

Cancer Diagnostics Market to Reach US$ 41.5 Billion by 2031 at 7.2% CAGR, says Wissen Research

SHERIDAN, Wyo., Oct. 15, 2026 /PRNewswire/ -- The global cancer diagnostics market is valued at USD 29.3 billion in 2026 and is projected to reach...

Medtronic Named to TIME Best Inventions of 2026 List for Stealth AXiS™ surgical system and Corsano™* multi-parameter wearable

Annual list recognizes inventions making the world better and smarterGALWAY, Ireland, Oct. 15, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare...

Bioprocess Technology Market to Reach USD 134.06 Billion by 2035 – Credence Research

LONDON, Oct. 15, 2026 /PRNewswire/ -- The "Bioprocess Technology Market – Growth, Share, Opportunities & Competitive Analysis, 2025–2035" report has been added to the...

XtalPi Nominates Its First siRNA Preclinical Candidate for IgA Nephropathy Nine Months After Program Initiation

Preclinical data demonstrate subnanomolar silencing potency, achieving an IC50 tens of times lower than the corresponding values for two clinical-stage reference molecules targeting the...

Neuroendocrine Prostate Cancer Market to Witness Growth at a 25% CAGR by 2036 Due to the Emergence of Emerging agents, including DLL3-targeted Therapies, ADCs,...

The neuroendocrine prostate cancer market is expected to grow steadily, driven by the rising recognition of NEPC as an aggressive and treatment-resistant form of...

Neuroendocrine Prostate Cancer Market to Witness Growth at a 25% CAGR by 2036 Due to the Emergence of Emerging agents, including DLL3-targeted Therapies, ADCs,...

The neuroendocrine prostate cancer market is expected to grow steadily, driven by the rising recognition of NEPC as an aggressive and treatment-resistant form of...

TOM BRADY’S WELLNESS & RECOVERY EDGE, NOW AVAILABLE TO EVERYONE: AESCAPE INTRODUCES THE BRADY PROTOCOL

One of the greatest athletes of all time made consistent recovery a practice that compounded over his career. Now his approach is available to...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTherapy